Cargando…
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
BACKGROUND & AIMS: Esophageal adenocarcinoma (EAC) develops from its precursor Barrett’s esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease progression is limited. Herein, we investigated th...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267443/ https://www.ncbi.nlm.nih.gov/pubmed/33774196 http://dx.doi.org/10.1016/j.jcmgh.2021.03.008 |
_version_ | 1783720147202080768 |
---|---|
author | Gotovac, Jovana R. Kader, Tanjina Milne, Julia V. Fujihara, Kenji M. Lara-Gonzalez, Luis E. Gorringe, Kylie L. Kalimuthu, Sangeetha N. Jayawardana, Madawa W. Duong, Cuong P. Phillips, Wayne A. Clemons, Nicholas J. |
author_facet | Gotovac, Jovana R. Kader, Tanjina Milne, Julia V. Fujihara, Kenji M. Lara-Gonzalez, Luis E. Gorringe, Kylie L. Kalimuthu, Sangeetha N. Jayawardana, Madawa W. Duong, Cuong P. Phillips, Wayne A. Clemons, Nicholas J. |
author_sort | Gotovac, Jovana R. |
collection | PubMed |
description | BACKGROUND & AIMS: Esophageal adenocarcinoma (EAC) develops from its precursor Barrett’s esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease progression is limited. Herein, we investigated the effect of Mothers against decapentaplegic homolog 4 (SMAD4) loss on transforming growth factor β (TGF-β) signaling functionality and in vivo tumorigenicity in high-grade dysplastic Barrett’s cells. METHODS: An in vivo xenograft model was used to test tumorigenicity of SMAD4 knockdown or knockout in CP-B high-grade dysplastic Barrett’s cells. RT(2) polymerase chain reaction arrays were used to analyze TGF-β signaling functionality, and low-coverage whole-genome sequencing was performed to detect copy number alterations upon SMAD4 loss. RESULTS: We found that SMAD4 knockout significantly alters the TGF-β pathway target gene expression profile. SMAD4 knockout positively regulates potential oncogenes such as CRYAB, ACTA2, and CDC6, whereas the CDKN2A/B tumor-suppressor locus was regulated negatively. We verified that SMAD4 in combination with CDC6-CDKN2A/B or CRYAB genetic alterations in patient tumors have significant predictive value for poor prognosis. Importantly, we investigated the effect of SMAD4 inactivation in Barrett’s tumorigenesis. We found that genetic knockdown or knockout of SMAD4 was sufficient to promote tumorigenesis in dysplastic Barrett’s esophagus cells in vivo. Progression to invasive EAC was accompanied by distinctive and consistent copy number alterations in SMAD4 knockdown or knockout xenografts. CONCLUSIONS: Altogether, up-regulation of oncogenes, down-regulation of tumor-suppressor genes, and chromosomal instability within the tumors after SMAD4 loss implicates SMAD4 as a protector of genome integrity in EAC development and progression. Foremost, SMAD4 loss promotes tumorigenesis from dysplastic Barrett’s toward EAC. |
format | Online Article Text |
id | pubmed-8267443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82674432021-07-16 Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus Gotovac, Jovana R. Kader, Tanjina Milne, Julia V. Fujihara, Kenji M. Lara-Gonzalez, Luis E. Gorringe, Kylie L. Kalimuthu, Sangeetha N. Jayawardana, Madawa W. Duong, Cuong P. Phillips, Wayne A. Clemons, Nicholas J. Cell Mol Gastroenterol Hepatol Original Research BACKGROUND & AIMS: Esophageal adenocarcinoma (EAC) develops from its precursor Barrett’s esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease progression is limited. Herein, we investigated the effect of Mothers against decapentaplegic homolog 4 (SMAD4) loss on transforming growth factor β (TGF-β) signaling functionality and in vivo tumorigenicity in high-grade dysplastic Barrett’s cells. METHODS: An in vivo xenograft model was used to test tumorigenicity of SMAD4 knockdown or knockout in CP-B high-grade dysplastic Barrett’s cells. RT(2) polymerase chain reaction arrays were used to analyze TGF-β signaling functionality, and low-coverage whole-genome sequencing was performed to detect copy number alterations upon SMAD4 loss. RESULTS: We found that SMAD4 knockout significantly alters the TGF-β pathway target gene expression profile. SMAD4 knockout positively regulates potential oncogenes such as CRYAB, ACTA2, and CDC6, whereas the CDKN2A/B tumor-suppressor locus was regulated negatively. We verified that SMAD4 in combination with CDC6-CDKN2A/B or CRYAB genetic alterations in patient tumors have significant predictive value for poor prognosis. Importantly, we investigated the effect of SMAD4 inactivation in Barrett’s tumorigenesis. We found that genetic knockdown or knockout of SMAD4 was sufficient to promote tumorigenesis in dysplastic Barrett’s esophagus cells in vivo. Progression to invasive EAC was accompanied by distinctive and consistent copy number alterations in SMAD4 knockdown or knockout xenografts. CONCLUSIONS: Altogether, up-regulation of oncogenes, down-regulation of tumor-suppressor genes, and chromosomal instability within the tumors after SMAD4 loss implicates SMAD4 as a protector of genome integrity in EAC development and progression. Foremost, SMAD4 loss promotes tumorigenesis from dysplastic Barrett’s toward EAC. Elsevier 2021-03-25 /pmc/articles/PMC8267443/ /pubmed/33774196 http://dx.doi.org/10.1016/j.jcmgh.2021.03.008 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Gotovac, Jovana R. Kader, Tanjina Milne, Julia V. Fujihara, Kenji M. Lara-Gonzalez, Luis E. Gorringe, Kylie L. Kalimuthu, Sangeetha N. Jayawardana, Madawa W. Duong, Cuong P. Phillips, Wayne A. Clemons, Nicholas J. Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus |
title | Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus |
title_full | Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus |
title_fullStr | Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus |
title_full_unstemmed | Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus |
title_short | Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus |
title_sort | loss of smad4 is sufficient to promote tumorigenesis in a model of dysplastic barrett’s esophagus |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267443/ https://www.ncbi.nlm.nih.gov/pubmed/33774196 http://dx.doi.org/10.1016/j.jcmgh.2021.03.008 |
work_keys_str_mv | AT gotovacjovanar lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT kadertanjina lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT milnejuliav lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT fujiharakenjim lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT laragonzalezluise lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT gorringekyliel lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT kalimuthusangeethan lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT jayawardanamadawaw lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT duongcuongp lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT phillipswaynea lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus AT clemonsnicholasj lossofsmad4issufficienttopromotetumorigenesisinamodelofdysplasticbarrettsesophagus |